+3S
A biomedical high-tech enterprise mainly engaged in antitoxin and antiserum. .
Launch date
Employees
Qingpu District China (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
CNY50.0m | Post IPO Equity | ||
| N/A | N/A | IPO | |
CNY50.0m | Post IPO Equity | ||
| Total Funding | - | ||
| Date | Investors | Amount | Round |
|---|---|---|---|
CNY50.0m | Post IPO Equity | ||
| N/A | N/A | IPO | |
CNY50.0m | Post IPO Equity | ||
| Total Funding | - | ||